DXCM · Healthcare · $32.4B
After-hours $85.94-0.34%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 114 Medical - Devices peers
Quarterly Revenue Growth
“매출 13% 성장(전년 동기 대비) — 최근 4분기 추이($1.2B→$1.3B→$1.2B→$1.3B)를 보면 성장이 정체 없이 유지되고 있어요.”
In the company's words · 2026 2분기 earnings call